This is a Validated Antibody Database (VAD) review about mouse Mta1, based on 6 published articles (read how Labome selects the articles), using Mta1 antibody in all methods. It is aimed to help Labome visitors find the most suited Mta1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Santa Cruz Biotechnology
mouse monoclonal (E-12)
  • chromatin immunoprecipitation; mouse; 1:1000; fig 2
Santa Cruz Biotechnology Mta1 antibody (Santa Cruz, sc-373765) was used in chromatin immunoprecipitation on mouse samples at 1:1000 (fig 2). Nat Commun (2014) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D40D1)
  • western blot; human; 1:1000; loading ...; fig 5c
Cell Signaling Technology Mta1 antibody (Cell Signaling Technology, 5647) was used in western blot on human samples at 1:1000 (fig 5c). Cancer Res (2021) ncbi
domestic rabbit monoclonal (D40D1)
  • western blot; human; fig 3c
Cell Signaling Technology Mta1 antibody (CST, 5647) was used in western blot on human samples (fig 3c). Nucleic Acids Res (2019) ncbi
domestic rabbit monoclonal (D40D1)
  • western blot; mouse; loading ...; fig 1c
Cell Signaling Technology Mta1 antibody (Cell Signaling Technology, 5647) was used in western blot on mouse samples (fig 1c). Mol Cell (2018) ncbi
domestic rabbit monoclonal (D40D1)
  • western blot; human; loading ...; fig 6c
Cell Signaling Technology Mta1 antibody (Cell signaling, D40D1) was used in western blot on human samples (fig 6c). J Exp Med (2016) ncbi
domestic rabbit monoclonal (D40D1)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 6
  • western blot; mouse; 1:1000; fig 6
  • western blot; human; 1:1000; fig 2
Cell Signaling Technology Mta1 antibody (Cell signaling, 5647) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 6), in western blot on mouse samples at 1:1000 (fig 6) and in western blot on human samples at 1:1000 (fig 2). Oncotarget (2016) ncbi
Articles Reviewed
  1. Zhao Z, Szczepanski A, Tsuboyama N, Abdala Valencia H, Goo Y, Singer B, et al. PAX9 Determines Epigenetic State Transition and Cell Fate in Cancer. Cancer Res. 2021;81:4696-4708 pubmed publisher
  2. Ivanochko D, Halabelian L, Henderson E, Savitsky P, Jain H, Marcon E, et al. Direct interaction between the PRDM3 and PRDM16 tumor suppressors and the NuRD chromatin remodeling complex. Nucleic Acids Res. 2019;47:1225-1238 pubmed publisher
  3. Bornelöv S, Reynolds N, Xenophontos M, Gharbi S, Johnstone E, Floyd R, et al. The Nucleosome Remodeling and Deacetylation Complex Modulates Chromatin Structure at Sites of Active Transcription to Fine-Tune Gene Expression. Mol Cell. 2018;71:56-72.e4 pubmed publisher
  4. Gay G, Braun L, Brenier Pinchart M, Vollaire J, Josserand V, Bertini R, et al. Toxoplasma gondii TgIST co-opts host chromatin repressors dampening STAT1-dependent gene regulation and IFN-?-mediated host defenses. J Exp Med. 2016;213:1779-98 pubmed publisher
  5. Dhar S, Kumar A, Zhang L, Rimando A, Lage J, Lewin J, et al. Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer. Oncotarget. 2016;7:18469-84 pubmed publisher
  6. Liu C, Yu Y, Liu F, Wei X, Wrobel J, Gunawardena H, et al. A chromatin activity-based chemoproteomic approach reveals a transcriptional repressome for gene-specific silencing. Nat Commun. 2014;5:5733 pubmed publisher